Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news



‘Cost savings and quality of life improvements’: Meta-analysis supports probiotics for common cold

By Stephen DANIELLS , 08-May-2014
Last updated on 12-May-2014 at 11:48 GMT2014-05-12T11:48:27Z

‘Cost savings and quality of life improvements’: Meta-analysis supports probiotics for common cold

Consuming probiotics may decrease the duration of common upper respiratory tract infections (URTI) by up to a day, compared to placebo, according to findings published in the British Journal of Nutrition .

Lactobacillus and/or Bifidobacterium strains present in yoghurt or dietary supplements were associated with fewer days of illness with a URTI per person, shorter illness episodes, and fewer days absent from daycare, school or work than participants who had taken a placebo.

The new review, which was authored by scientists from the York Health Economics Consortium (UK) and Dairy and Food Culture Technologies (California), was funded by the Global Alliance for Probiotics (GAP).

“The core of nutrition science is to advise on the construction of a diet that helps maintain health and reduce risk of disease,” said the paper’s lead author, Dr Sarah King, affiliated with York Health Economics Consortium (YHEC). “This paper shows that with the addition of live lactobacilli and bifidobacteria to your diet, the duration of upper respiratory tract infections (e.g. colds) could be shortened.

“Combined with results from a 2011 meta-analysis published in the Cochrane Database of Systematic Reviews, which demonstrated that probiotics can reduce the incidence of URTIs, the implications of these findings are significant, and could translate into cost savings and quality of life improvements.”

The cost savings could be significant, with data from the US Centers for Disease Control and Prevention indicating that 22 million school days and 20 million workdays in adults are lost annually due to the common cold in the USA. In addition, the economic impact of colds in the US is estimated to be about $40 billion every year.

Probiotics are defined as "live microorganisms which when administered in adequate amounts confer a health benefit on the host".

Meta-analysis details

Dr King and her co-authors evaluated the effects of different strains of Lactobacillus and Bifidobacterium on the duration of acute respiratory infections in otherwise healthy children and adults. Twenty randomized controlled trials (RCT) were identified from various scientific databases, of which 12 were considered to have a low risk of bias.

Crunching the numbers revealed that probiotics were associated with significantly fewer numbers of days of illness per person, as well as shorter illness episodes by almost a day, and fewer numbers of days absent from day care/school/work, compared to placebo.

“However, there was significant statistical heterogeneity between the studies that reported on the duration of illness episodes and those that reported on absenteeism from day care/school/work, but not for studies that reported on the number of days of illness per person,” wrote the authors. “This unexplained heterogeneity means that the effect size (i.e. the difference in the duration of illness episodes between treated and untreated individuals) may differ between the population groups.”

Dr King and her co-authors called on more research and additional meta-analyses to elucidate any differences between population groups.

Source: British Journal of Nutrition
Published online ahead of print, doi: 10.1017/S0007114514000075
“Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis”
Authors: S. King, J. Glanville, M.E. Sanders, A. Fitzgerald, D. Varley

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars